Juniper Point, Author at Longboard Pharmaceuticals

About Juniper Point

This author has not yet filled in any details.
So far Juniper Point has created 5 blog entries.

Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives

Juniper Point2023-03-24T08:32:24+00:0003.02.2023|

Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023

Juniper Point2023-03-24T08:32:24+00:0002.23.2023|

Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Common Stock

Juniper Point2023-03-24T08:32:24+00:0002.10.2023|

Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting.

Download PDF Two poster presentations highlight Phase 1 data for [...]

Juniper Point2023-03-20T16:12:29+00:0004.01.2022|

Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference

Jan 5, 2022 Download PDF Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), [...]

Juniper Point2023-03-20T16:12:30+00:0001.05.2022|